Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,968,945
+$33,462 QoQ
Shares Held
119,116
+4.6% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,506,832,621 across 316 Biotechnology names. IDYA ranks #112 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in IDYA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,968,945 | 119,116 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,935,483 | 113,841 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,985,263 | 109,712 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,292,551 | 156,639 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,675,307 | 468,578 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,890,991 | 423,774 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,795,331 | 498,590 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,225,680 | 604,548 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,058,933 | 479,921 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,507,287 | 70,469 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,961,661 | 72,708 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,390,378 | 271,931 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,454,149 | 324,410 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,543,127 | 139,963 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $177,548 | 11,900 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $361,656 | 26,207 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,890,701 | 258,329 | Shares | Sole | 2022-05-16 | |
| 2021-06-30 | $492,698 | 23,473 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,767,148 | 117,751 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,439,472 | 174,248 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,273,046 | 180,975 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $324,712 | 22,851 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||